Final answer:
By migrating to cloud computing, a pharmaceutical firm can achieve sustainable benefits including reduced energy consumption, decreased hardware production, and a lower carbon footprint. These benefits result from increased efficiency and the environmental practices adopted by cloud providers.
Step-by-step explanation:
The sustainable benefit a pharmaceutical firm will achieve by migrating their applications from enterprise-owned servers to the cloud includes reduced energy consumption, decreased hardware production, and a lower carbon footprint. These benefits are tied to more efficient use of resources, as cloud providers can optimize the energy utilization of their infrastructure more effectively than individual enterprises often can. Additionally, cloud service providers often have a focus on environmentally friendly practices, such as using renewable energy sources and designing greener, more efficient, and longer-lasting products.
By shifting to cloud computing, the firm not only decreases the direct energy consumption of its own data centers but also contributes to reduced emissions from the manufacturing of servers and other hardware, as the need for these diminishes. Furthermore, cloud providers often incorporate practices to reduce environmental impacts throughout their operations, implying that by choosing to migrate to the cloud, the firm aligns itself with partners that prioritize environmental sustainability.